Discontinued — last reported Q4 '25
Share-Based Compensation Expense, Net of Tax
Medtronic Share-Based Compensation Expense, Net of Tax decreased by 49.7% to $77.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 4.9%, from $81.00M to $77.00M. Over 4 years (FY 2021 to FY 2025), Share-Based Compensation Expense, Net of Tax shows an upward trend with a 6.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
An increase indicates higher equity-based compensation costs, which may dilute shareholders or reflect increased incentive spending.
Detailed definition
Represents the total expense recognized for share-based payment arrangements, such as stock options or restricted stock...
Peer comparison
Standard across public companies, though accounting methods for tax benefits can vary.
is_ibm_share_based_compensation_net_of_taxHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $118.00M | $58.00M | $114.00M | $65.00M | $97.00M | $51.00M | $111.00M | $67.00M | $116.00M | $62.00M | $121.00M | $70.00M | $134.00M | $70.00M | $134.00M | $81.00M | $143.00M | $71.00M | $153.00M | $77.00M |
| QoQ Change | — | -50.8% | +96.6% | -43.0% | +49.2% | -47.4% | +117.6% | -39.6% | +73.1% | -46.6% | +95.2% | -42.1% | +91.4% | -47.8% | +91.4% | -39.6% | +76.5% | -50.3% | +115.5% | -49.7% |
| YoY Change | — | — | — | — | -17.8% | -12.1% | -2.6% | +3.1% | +19.6% | +21.6% | +9.0% | +4.5% | +15.5% | +12.9% | +10.7% | +15.7% | +6.7% | +1.4% | +14.2% | -4.9% |
Share-Based Compensation Expense, Net of Tax at Other Companies
Frequently Asked Questions
- What is Medtronic's share-based compensation expense, net of tax?
- Medtronic (MDT) reported share-based compensation expense, net of tax of $77.00M in Q1 2026.
- How has Medtronic's share-based compensation expense, net of tax changed year-over-year?
- Medtronic's share-based compensation expense, net of tax decreased by 4.9% year-over-year, from $81.00M to $77.00M.
- What is the long-term trend for Medtronic's share-based compensation expense, net of tax?
- Over 4 years (2021 to 2025), Medtronic's share-based compensation expense, net of tax has grown at a 6.8% compound annual growth rate (CAGR), from $344.00M to $448.00M.
- What does share-based compensation expense, net of tax mean?
- The after-tax cost of equity-based compensation provided to employees.